Physician profile
Hammad Nazeer
NPI 1255628814
$7,855.07
in general payments reported to CMS, 2019-2025
55 companies · $2,717 in 2025
The $2,717 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.13 · 2021: $95.09 · 2022: $1,000 · 2023: $1,724 · 2024: $2,235 · 2025: $2,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,600 · Education: $76.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,600.02 |
| Education | $76.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $689.75 | 2020-2025 | Afrezza |
| Amgen INC. | $606.01 | 2022-2025 | Tepezza, Evenity, Prolia |
| Lilly USA, LLC | $582.72 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $518.74 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $482.36 | 2021-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $385.23 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Insulet Corporation | $334.60 | 2022-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $286.55 | 2023-2025 | |
| Dexcom, INC. | $280.40 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $267.52 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Bayer Healthcare Pharmaceuticals INC. | $264.23 | 2022-2025 | |
| Tandem Diabetes Care, INC. | $257.94 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Neurocrine Biosciences, INC. | $234.90 | 2024-2025 | |
| Antares Pharma, INC. | $192.78 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Cequr Corporation | $142.18 | 2022-2025 | Cequr Simplicity |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $132.48 | 2022-2025 | Tymlos |
| Acella Pharmaceuticals, LLC | $132.31 | 2022-2025 | NP Thyroid 60 |
| Verity Pharmaceuticals INC. | $126.35 | 2024-2025 | Tlando |
| Ascendis Pharma Endocrinology INC | $119.62 | 2023-2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $114.01 | 2023-2025 | Strensiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.90 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $104.36 | 2022-2023 | Farxiga |
| Recordati_rare_diseases_inc. | $98.50 | 2023-2024 | Isturisa, Signifor Lar |
| Sequel Med Tech, LLC | $96.97 | 2025 | Twiist |
| Esperion Therapeutics, INC. | $94.28 | 2023-2025 | Nexletol |
| Abbott Laboratories | $91.98 | 2023-2025 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $89.24 | 2022-2025 | Tirosint, Licart, Flector |
| Ascensia Diabetes Care US INC. | $84.03 | 2024 | |
| Madrigal Pharmaceuticals | $77.96 | 2025 | Rezdiffra |
| Beta Bionics, INC. | $77.19 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amneal Pharmaceuticals LLC | $68.54 | 2022-2023 | Unithroid |
| Medtronic Minimed, INC. | $63.75 | 2020 | |
| Amarin Pharma, INC. | $58.58 | 2022-2023 | |
| Astellas Pharma US INC | $56.90 | 2024-2025 | Veozah |
| Rhythm Pharmaceuticals, INC. | $50.83 | 2024-2025 | Imcivree |
| Avvisto Therapeutics, LLC | $47.80 | 2024-2025 | Cycloset |
| Tolmar, INC. | $45.97 | 2023-2025 | Jatenzo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.64 | 2022-2023 | Cycloset |
| Novartis Pharmaceuticals Corporation | $34.00 | 2022-2023 | |
| Soleno Therapeutics, INC. | $31.91 | 2025 | Vykat Xr |
| Abbvie INC. | $27.51 | 2024 | |
| Sandoz INC. | $27.49 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $23.14 | 2023 | Livalo |
| Horizon Therapeutics Plc | $21.02 | 2023 | Tepezza |
| Glaxosmithkline, LLC. | $20.73 | 2025 | Arexvy |
| Amphastar Pharmaceuticals, INC. | $19.63 | 2025 | |
| Azurity Pharmaceuticals, INC. | $17.70 | 2025 | Azmiro |
| Amryt Pharma Holdings LTD | $17.68 | 2023 | Mycapssa |
| Alvogen INC | $17.33 | 2025 | Teriparatide |
| Regeneron Healthcare Solutions, INC. | $16.84 | 2025 | Evkeeza |
| Pfizer INC. | $16.70 | 2023 | |
| Currax Pharmaceuticals LLC | $15.70 | 2025 | Contrave |
| Halozyme INC | $14.14 | 2023 | |
| Lifescan, INC. | $13.48 | 2022 | |
| Nevro Corp. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Nazeer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.